What are the guidelines for using Orphenadrine citrate in an adult patient with a history of glaucoma, prostate enlargement, or gastrointestinal obstruction, experiencing muscle spasms or pain, possibly due to back pain or fibromyalgia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Orphenadrine Citrate: Contraindicated in Patients with Glaucoma, Prostate Enlargement, or Gastrointestinal Obstruction

Orphenadrine citrate is absolutely contraindicated in patients with glaucoma, prostatic hypertrophy or bladder neck obstruction, and gastrointestinal obstruction (including pyloric or duodenal obstruction and stenosing peptic ulcers), and should not be used in these clinical scenarios. 1

Absolute Contraindications

The FDA drug label explicitly lists the following as contraindications for orphenadrine citrate 1:

  • Glaucoma (all types)
  • Prostatic hypertrophy or bladder neck obstruction
  • Pyloric or duodenal obstruction
  • Stenosing peptic ulcers
  • Cardiospasm (megaesophagus)
  • Myasthenia gravis
  • Previous hypersensitivity to orphenadrine

Mechanism of Harm in Contraindicated Conditions

Orphenadrine citrate possesses significant anticholinergic properties that directly worsen the pathophysiology of these conditions 1:

  • In glaucoma patients: Anticholinergic agents cause pupillary dilation, which can precipitate acute angle-closure glaucoma by blocking aqueous humor drainage 2. This represents a vision-threatening emergency.

  • In prostatic hypertrophy/bladder neck obstruction: Anticholinergic effects impair bladder detrusor muscle contraction and can precipitate acute urinary retention requiring catheterization 2.

  • In gastrointestinal obstruction: Anticholinergic properties reduce gastrointestinal motility and can worsen or precipitate complete obstruction 2.

Clinical Decision Algorithm

When a patient presents with muscle spasm or musculoskeletal pain:

  1. Screen for absolute contraindications before considering orphenadrine 1:

    • Ask specifically about glaucoma history (any type, including narrow-angle or open-angle)
    • Ask about urinary symptoms suggesting prostatic enlargement (hesitancy, weak stream, nocturia, incomplete emptying)
    • Ask about gastrointestinal symptoms suggesting obstruction or severe motility disorders
    • Document any history of myasthenia gravis

  2. If ANY contraindication is present: Do not prescribe orphenadrine under any circumstances 1.

  3. Alternative approaches for muscle spasm/pain when orphenadrine is contraindicated:

    • NSAIDs or acetaminophen for pain control 3
    • Physical therapy and non-pharmacologic modalities (massage, heat/cold therapy) 3
    • Consider muscle relaxants without significant anticholinergic properties (cyclobenzaprine has some anticholinergic effects but less than orphenadrine; methocarbamol or tizanidine may be safer alternatives)
    • Opioid analgesics for severe pain if other measures fail, though these carry their own risks 3

Dosing When Appropriate (No Contraindications Present)

If orphenadrine is deemed appropriate after ruling out all contraindications 1:

  • Parenteral: 60 mg (one 2 mL vial) intravenously or intramuscularly, may be repeated every 12 hours
  • Oral maintenance: 100 mg tablet twice daily after initial parenteral relief

Critical Pitfalls to Avoid

  • Do not assume "mild" glaucoma is safe: All forms of glaucoma are absolute contraindications 1. Even patients with well-controlled open-angle glaucoma on topical therapy should not receive orphenadrine due to risk of precipitating angle closure.

  • Do not overlook subclinical prostatic symptoms: Men over 50 with any urinary hesitancy, frequency, or nocturia likely have some degree of prostatic enlargement and are at risk for acute retention 2.

  • Do not combine with other anticholinergic agents: The additive anticholinergic burden dramatically increases risk of urinary retention, constipation, confusion, and other adverse effects 2.

  • Do not use in elderly patients without extreme caution: Older adults have increased sensitivity to anticholinergic effects, including delirium, cognitive decline, falls, and all the contraindicated conditions become more prevalent with age 2.

Evidence Quality Note

The contraindications listed are derived from the FDA-approved drug label 1, which represents the highest level of regulatory authority for medication safety. These are not relative contraindications or precautions—they are absolute contraindications where the risk of serious harm outweighs any potential benefit for muscle spasm relief.

References

2
Guideline

Use of Diphenhydramine in Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Related Questions

What is the appropriate management for a 37‑year‑old woman with a one‑week history of eyelid swelling, watery and blurry vision, who has been using oral loratadine (Claritin) and erythromycin ophthalmic ointment with partial improvement but persistent eye ache?
What are the first-line medications for treating glaucoma?
What medications commonly used in dementia patients can cause pinpoint (constricted) pupils?
What are the cautions for using quetiapine (antipsychotic medication) in patients with ophthalmic (eye) conditions?
Is a worsening lump on the left eyelid of a patient with a one‑year history of eye problems who is taking quetiapine 200 mg daily and valproic acid (Convulex) 300 mg daily likely a meibomian cyst?
What is the recommended treatment for a patient with hives and itching, considering potential comorbidities such as diabetes, hypertension, or osteoporosis?
Can a patient develop a hernia above the umbilical line, halfway between the midline and the mid axillary line?
What are the risks and benefits of penicillin (Penicillin G) administration for a pregnant patient who is Group B Streptococcus (GBS) positive during labor?
What is the recommended management for a patient who is a Group A Streptococcus (Strep A) carrier with no signs of streptococcal pharyngitis, but has tonsils present?
What alternative antibiotic can be used for a pregnant patient with a bacterial infection, such as bacterial vaginosis or pelvic inflammatory disease, who has failed treatment with azithromycin (Zithromax)?
What is the differential diagnosis for a patient who feels a pop in the abdominal wall while straining to stool, possibly due to constipation or straining during bowel movements?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.